The 2X Blend combines Tesamorelin and Ipamorelin, two research peptides that interact with different parts of the growth hormone signaling system. Tesamorelin is modeled after growth hormone-releasing hormone (GHRH), while Ipamorelin interacts with the growth hormone secretagogue receptor (GHS-R).
Research involving these compounds has explored growth hormone signaling, IGF-1 activity, pituitary function, metabolic processes, and body composition. Because the peptides act through different receptor pathways, researchers can study how GHRH and GHS-R signaling relate to one another within the broader endocrine system.
Ophir Health 2X Blend Tesamorelin / Ipamorelin provides a combined format for laboratory research involving growth hormone pathways, pituitary signaling, IGF-1 activity, metabolic regulation, and endocrine biology.
